Pyrin inflammasome activation and RhoA signaling in the autoinflammatory diseases FMF and HIDS - Wikidata - wikimedia - TriplyDB

Pyrin inflammasome activation and RhoA signaling in the autoinflammatory diseases FMF and HIDS

Pyrin inflammasome activation and RhoA signaling in the autoinflammatory diseases FMF and HIDS

http://www.wikidata.org/entity/Q28596027

about

APC/CCdh1-Rock2 pathway controls dendritic integrity and memory.Potential of IL-1, IL-18 and Inflammasome Inhibition for the Treatment of Inflammatory Skin Diseases.Lipin-2 regulates NLRP3 inflammasome by affecting P2X7 receptor activation.The Yersinia pestis Effector YopM Inhibits Pyrin Inflammasome Activation.Familial Mediterranean fever mutations lift the obligatory requirement for microtubules in Pyrin inflammasome activation.Familial Mediterranean Fever: Recent Developments in Pathogenesis and New Recommendations for Management Geoepidemiology and Immunologic Features of Autoinflammatory Diseases: a Comprehensive Review.A systematic approach to autoinflammatory syndromes: a spelling booklet for the beginner.Genetic and Epigenetic Determinants in Autoinflammatory Diseases.Canakinumab for the treatment of familial Mediterranean fever.Autoinflammatory diseases: update on classification diagnosis and management.The burgeoning field of innate immune-mediated disease and autoinflammation.Acting on Actin: Rac and Rho Played by Yersinia.Lessons from characterization and treatment of the autoinflammatory syndromes.The NLRP3 and Pyrin Inflammasomes: Implications in the Pathophysiology of Autoinflammatory Diseases.Molecular mechanisms and functions of pyroptosis, inflammatory caspases and inflammasomes in infectious diseases.Interleukin-1 Blockade: An Update on Emerging Indications.Mechanisms governing inflammasome activation, assembly and pyroptosis induction.Posttranslational Modification as a Critical Determinant of Cytoplasmic Innate Immune Recognition.Autoinflammatory Diseases with Periodic Fevers.Genomics, Biology, and Human Illness: Advances in the Monogenic Autoinflammatory Diseases.The monogenic autoinflammatory diseases define new pathways in human innate immunity and inflammation.A novel Pyrin-Associated Autoinflammation with Neutrophilic Dermatosis mutation further defines 14-3-3 binding of pyrin and distinction to Familial Mediterranean Fever.Open-Label, Phase II Study to Assess the Efficacy and Safety of Canakinumab Treatment in Active Hyperimmunoglobulinemia D With Periodic Fever Syndrome.Clinical update on inflammasomopathies.Metabolism in Immune Cell Differentiation and Function.[Role of genetics in familial Mediterranean fever].IL-1β and Caspase-1 Drive Autoinflammatory Disease Independently of IL-1α or Caspase-8 in a Mouse Model of Familial Mediterranean Fever.Inflammasome assembly in the chorioamniotic membranes during spontaneous labor at term.The Yersinia Virulence Factor YopM Hijacks Host Kinases to Inhibit Type III Effector-Triggered Activation of the Pyrin Inflammasome.A dRAStic RHOAdblock of Pyrin inflammasome activation.Protection against lupus-like inflammatory disease is in the LAP of non-canonical autophagy.Autoimmunity and autoinflammation: A systems view on signaling pathway dysregulation profiles.Comprehensive analysis of mutations in the MEFV gene reveal that the location and not the substitution type determines symptom severity in FMF.Late ventricular potentials in familial Mediterranean fever with and without AA amyloidosis.Inflammasome activation and assembly at a glance.Checks and Balances between Autophagy and Inflammasomes during Infection.Recent advances in inflammasome biology.Autophagy dysfunction in autoinflammatory diseases.Familial Mediterranean fever mutations are hypermorphic mutations that specifically decrease the activation threshold of the Pyrin inflammasome.

P2860

Q33620199-CFD2C8B7-E051-4186-9540-33C843BE4DDD Q33710807-57F5229B-7008-4589-82D6-DA46B6809432 Q34680399-326C63E7-D5CD-4FBF-B066-8ECA7242CE57 Q36212027-7DDB8DEB-D13F-42E8-96E1-2974A25EA940 Q37515104-9863EA51-C29D-47FE-B189-CAA3AA255379 Q37716794-B02532F4-80A8-472B-A191-3031E74E57E8 Q38746358-2CBD6399-1435-4326-A27C-C13ACFA16AFA Q38773387-5052CBC4-475E-4D4E-90BB-2964FBE772CE Q38851405-1AFF87F8-0D1C-49B4-B676-5172178E1125 Q38865019-964431D6-79FD-430C-A35C-EC2BAF0BB4C1 Q38959075-A6C0B5F5-BF06-45BC-BDC6-4CB2E21936BA Q38967233-F332965B-4B6B-4011-AFCC-568C22B421F2 Q38981726-187847E6-298F-40CA-9E93-19CF41C0BF6E Q39025839-3663A9D8-749A-4EB1-8629-1DDD3C4A0B4B Q39132605-34C5465E-CA9F-402E-89BD-900AF4F6C977 Q39277467-ECA32626-F822-4CCC-9A0C-212181F81C58 Q39301613-6C272530-D0D1-4919-8524-C9879E8F5947 Q39322410-F53E9439-9290-4973-8579-6E4F657AD553 Q39374120-98ED616B-FEBD-4A74-9218-E251A493333F Q39384980-A2EBB4D6-DA6F-4215-8BBF-BE3C1CE4D59C Q39436645-FFC0DDD8-63EC-459B-A54E-F438C04ECCD4 Q39443996-2316DFB0-3022-4FAC-AFD4-279DF7801B19 Q40042168-E3F8F3DE-E901-4DC5-B959-89A4770F04FF Q40057989-2832209D-926B-4ADA-A4FD-23B488E21A5A Q40062051-BBBD9758-5CA5-4B2A-AABE-B68605CE453F Q40065267-467AF043-B7FA-42AF-9D66-4F8E6F3D17AC Q40070578-3A30EC49-3091-402F-BF59-6ABB4DA6FE48 Q40075783-81B48BE4-2FEC-47DB-8229-EF1E8422D7CC Q40319524-DBC57D88-2C53-4C2C-8293-76F48A28AC84 Q40560457-ADDD0290-69C9-469C-A754-272B6DB1BC44 Q41911141-6D55A60C-0403-4E42-B5F6-CE72C764DC85 Q42330845-2BD7BD9A-088A-484B-AAB3-5F211F8591DE Q45607380-C2DC89CA-061A-4CF9-9F3E-CB44D3BDFB68 Q45947333-2AC7823C-6263-4B2A-9C86-2AA9D3DFF5CC Q47109776-AEBB1D86-7D05-4ABA-A696-EABF6498F749 Q47340381-3ABA0D99-9943-4775-9437-7698B2604662 Q47377687-09D332ED-CAA4-49E3-9C49-03D0C7C61581 Q47412881-75B44FB4-8579-43C7-B407-AD90A068FBC1 Q47434993-1E102935-DF1A-4D10-BA81-0780C055B925 Q47638843-C8A6F2EA-E360-4CA2-80E5-9EC3B5E4CC90

P2860

Pyrin inflammasome activation and RhoA signaling in the autoinflammatory diseases FMF and HIDS

http://www.wikidata.org/entity/Q28596027

description

2016 nî lūn-bûn

@nan

2016 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Pyrin inflammasome activation ...... ammatory diseases FMF and HIDS

@ast

Pyrin inflammasome activation ...... ammatory diseases FMF and HIDS

@en

Pyrin inflammasome activation ...... ammatory diseases FMF and HIDS

@nl

type

label

Pyrin inflammasome activation ...... ammatory diseases FMF and HIDS

@ast

Pyrin inflammasome activation ...... ammatory diseases FMF and HIDS

@en

Pyrin inflammasome activation ...... ammatory diseases FMF and HIDS

@nl

prefLabel

Pyrin inflammasome activation ...... ammatory diseases FMF and HIDS

@ast

Pyrin inflammasome activation ...... ammatory diseases FMF and HIDS

@en

Pyrin inflammasome activation ...... ammatory diseases FMF and HIDS

@nl

P1433

Q28596027-EC7C35DC-0E7E-45F5-9859-6D2EA80E529E

P1476

Q28596027-CC56E405-14CC-45C0-B98E-4F6AB3C0471A

P2093

Q28596027-04688664-5B17-4DB1-92CF-63A71E93E93B

Q28596027-2EA55DEA-11E5-439D-93A8-60D000E0F1D2

Q28596027-BA9C7EA3-8AA9-4BB2-8218-DE3D5B5CFD13

Q28596027-D1550CEB-C45C-43E3-9A20-2A2CBDA90332

P2860

Q28596027-01F6AEBB-6EEB-4207-91F7-DDF0C6083BFB

Q28596027-0231F2B5-5EF2-496F-8CE9-A8DE14CABB2B

Q28596027-06DC8195-265B-4875-86D7-7085671BDEA8

Q28596027-11A5EA25-3E2C-425D-94D1-FDE81EC12778

Q28596027-1B2FFB86-B1FE-4A6F-89B0-660ECE317D7E

Q28596027-245992E4-07FD-41E7-B5D8-2D2166B5E59A

Q28596027-322FFED3-2CBF-4B56-98C2-5F8542107643

Q28596027-395375BC-317A-48CD-9752-FF2F7B625E25

Q28596027-450B9E1C-CFCE-473E-8907-64DE7CACEEC1

Q28596027-53B283C4-62F9-441D-A349-2145E0015E79

P304

Q28596027-A13373A7-118E-45E6-8E26-FAE9488D8B35

P31

Q28596027-FB6E0E89-89DD-4C6C-981C-5E4CA3454771

P3181

Q28596027-8C5657AB-0251-4FD0-B10A-A69A2F6EED09

P356

Q28596027-CA6E5522-34D9-4BC6-9D08-274A65F14D05

P407

Q28596027-2627E275-A702-4EAD-9040-D9A6FC35AE2F

P433

Q28596027-AF6510DB-86B0-4B10-A8CD-583C46C7EF24

P478

Q28596027-AD9F5430-D22C-4D1A-A8AA-D90C1160DA9B

P577

Q28596027-A367A33F-100D-46BA-A74A-B2423E798EEB

P698

Q28596027-157C28FB-812A-414A-86C9-C1CCC55C3DBC

P921

Q28596027-5EC05099-CCE4-48F5-9A4D-98333418D43E

P932

Q28596027-E059517C-5CA7-4AA8-BB40-1D24EB56939C

P3181

P356

P1433

Nature Immunology

P1476

Pyrin inflammasome activation ...... ammatory diseases FMF and HIDS

@en

P2093

Daniel L Kastner

http://www.w3.org/2001/XMLSchema#string

Geryl Wood

http://www.w3.org/2001/XMLSchema#string

Jae Jin Chae

http://www.w3.org/2001/XMLSchema#string

Yong Hwan Park

http://www.w3.org/2001/XMLSchema#string

P2860

Nucleotide exchange factor GEF-H1 mediates cross-talk between microtubules and the actin cytoskeleton

Clinical and subclinical inflammation in patients with familial Mediterranean fever and in heterozygous carriers of MEFV mutations

Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease (*)

The plant immune system

Rho-associated kinase of chicken gizzard smooth muscle

Microtubule-driven spatial arrangement of mitochondria promotes activation of the NLRP3 inflammasome

Mutational analysis of the regulatory mechanism of PKN: the regulatory region of PKN contains an arachidonic acid-sensitive autoinhibitory domain

Mutations in the gene encoding mevalonate kinase cause hyper-IgD and periodic fever syndrome. International Hyper-IgD Study Group.

A candidate gene for familial Mediterranean fever.

Enzymes of the mevalonate pathway of isoprenoid biosynthesis

P304

914-21

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4794015

http://www.w3.org/2001/XMLSchema#string

P356

10.1038/NI.3457

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P577

2016-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27270401

http://www.w3.org/2001/XMLSchema#string

P921

P932

4955684

http://www.w3.org/2001/XMLSchema#string